Premature Ovarian Insufficiency Clinical Trial
Official title:
Study of Ventricular Repolarization in Patients With Premature Ovarian Insufficiency and Influence of Estrogen-progestin Replacement Therapy
Ventricular repolarization, measured by corrected QT interval (QTc), is influenced by sex hormones. A QTc above 460msec predisposes to the risk of "torsades-de-pointes"(TdP). The investigators have recently shown that estradiol determines an increase in QTc elongation and progesterone shortens it. In addition, high gonadotropin levels (FSH or LH) are associated with QTc prolongation. Hypergonadotropic hypogonadisms (low progesterone and high gonadotropins) are therefore hormonal situations that promote QTc prolongation. Premature ovarian insufficiency (POI) is one of them. Its management is based on the prescription of hormone replacement therapy (HRT). Epidemiological studies have shown that these patients would be at increased risk of cardiovascular mortality. Our team is interested in the effect of this pathological hormonal situation and its HRT on ventricular repolarization in order to define whether this is a population at risk for long QTc.
Ventricular repolarization, measured by the duration of the heart rate corrected QT interval (QTc), is influenced by sex hormones. A QTc above 460msec predisposes to the risk of torsades-de-pointes (TdP); ventricular arrhythmias that can lead to sudden death. From puberty to menopause, QTc is longer in women than in men (~10-15msec difference) and varies in women according to the menstrual cycle (~5-10msec). This explains the increased risk of TdP in women compared to men. During the menstrual cycle, the risk is highest for women during the follicular phase compared to the luteal phase. The investigators have recently shown that estradiol determines an increase in QTc elongation and progesterone shortens it. In addition, high gonadotropin levels (FSH or LH) are associated with QTc prolongation. Hypergonadotropic hypogonadisms (low progesterone and high gonadotropins) are therefore hormonal situations that promote QTc prolongation. Premature ovarian insufficiency (POI) affects 1% of women under 40 years of age and is characterized by hypergonadotropic hypogonadism. POI is associated with hormonal deficiencies responsible for amenorrhea and infertility. Management is based on the prescription of hormone replacement therapy (HRT). Epidemiological studies have shown that these patients would be at increased risk of cardiovascular mortality. HRT will be based on the combination of an estrogen and a progestin and will lead to a variable decrease in gonadotropins, depending on the steroid hormones/doses used. Our team, after structuring one of the largest international cohorts of patients with POI, is interested in the effect of this pathological hormonal situation and its HRT on ventricular repolarization to define whether this is a population at risk for long QTc. Indeed, ECG follow-up is recommended and many drugs (cardiovascular or not), are to be avoided, or even contraindicated in situations at risk of long QTc. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06072794 -
A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI)
|
Phase 1 | |
Recruiting |
NCT06096766 -
the Correlation Between Ovarian Function and Serum Biomarkers
|
||
Completed |
NCT04641624 -
sFlt- 1, PIGF, and Niacin Levels in Women With Premature Ovarian Insufficiency
|
||
Recruiting |
NCT05308342 -
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency
|
N/A | |
Not yet recruiting |
NCT06067529 -
A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency
|
||
Recruiting |
NCT05665010 -
Precise Stratification of Genetic Risk of Ovarian Function Impairment
|
||
Not yet recruiting |
NCT05385848 -
Autologous Platelet-rich Plasma (PRP) Infusion to Improve Outcomes in Women With Ovarian Insufficiency: a Pilot Study
|
N/A | |
Completed |
NCT04475744 -
4-step ASCOT in POI Women to Promote Follicular Rescue
|
Phase 3 | |
Recruiting |
NCT05279560 -
Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation
|
N/A | |
Recruiting |
NCT06302543 -
Treatment of Premature Ovarian Insufficiency Using Bone Marrow Cells
|
N/A | |
Recruiting |
NCT06145061 -
Evaluation on Biological Characteristics of Acupoints in Premature Ovarian Insufficiency
|
||
Recruiting |
NCT05858307 -
Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements
|
||
Completed |
NCT06228547 -
Women's Experience of Premature Ovarian Insufficiency (POI) Diagnosis: Update on Actual Practices and Patient's Follow up
|
||
Recruiting |
NCT06102655 -
Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics
|
Early Phase 1 | |
Recruiting |
NCT05485610 -
Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)
|
N/A | |
Recruiting |
NCT05586737 -
Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency
|
Phase 2 | |
Not yet recruiting |
NCT06339489 -
The Bone Metabolism Characteristics of Premature Ovarian Insufficiency
|